EUVIMED · CrossrefJournal
European Heart Journal
ISSN 0195-668X · Oxford University Press (OUP)
Latest articles
Correction to: Vitamin C and cardiovascular disease
One to move, one to clip: double transcatheter edge-to-edge repair technique for mitral regurgitation after annuloplasty ring dehiscence
Latent outflow tract obstruction in hypertrophic cardiomyopathy: the diagnostic role of postprandial echocardiography
Toxic lymphocytic myocarditis after H2S exposure: imaging and biopsy
Intramyocardial lipoma: a contrast echocardiography pitfall
The silent strangler: dynamic tricuspid-pulmonary obstruction in intravenous leiomyomatosis
Menopause hormone therapy, reproductive factors, and incident heart failure: reframing hormonal exposure in women’s cardiovascular risk
Weekly Journal Scan: Less-than- OPTIMAl evidence for a shorter duration of dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation
What constitutes healing after silent plaque rupture?
Defining silent plaque rupture healing in vivo: a structural approach by OCT
Peri-aortic fat imaging: a window to vascular ageing
Same ejection fraction, different patient: has the defibrillator outlived its own trial data?
Heart failure therapy for congenitally corrected transposition of the great arteries: a new paradigm for congenital heart disease?
Not all ultra-processed foods are equal: refining their role in cardiovascular risk
Clonal haematopoiesis across the cardiovascular–kidney–metabolic continuum: from risk marker to therapeutic target
Beyond lipid content: proteomic insights into the atherogenicity of lipoprotein particles
Vasodilation in heart failure with reduced ejection fraction: right patient, right time?
One atrial impulse, two pathways, alternating bundle branch block
TARGET-D: vitamin D thresholds and assumptions about cardiovascular benefit
25-Hydroxyvitamin D: what is the target?
SCORE2 for Latin America and the Caribbean: adding another piece to the global puzzle of cardiovascular risk prediction
Alcohol and cardiovascular disease: inter-organ crosstalk, microvascular dysfunction, and cardiovascular ageing
Oral anticoagulation and cognitive outcomes in atrial fibrillation and Alzheimer’s disease
Oral anticoagulation and cognitive outcomes in atrial fibrillation and Alzheimer’s disease: considerations for longitudinal analyses
Is local coronary inflammation truly superior after PCI, or is the comparison driven by revascularization endpoints?
Local and systemic inflammation after percutaneous coronary intervention: complementary risk signals beyond revascularization
The ESC Digital Cardiology and Artificial Intelligence Learning Pathway
Ten commandments for the management of cardiovascular disease and chronic kidney disease
Seven hundred scientists, one network: inside CIBER-CV
Cardio-renal-metabolic health checks: why we must act quickly
Volumes
2026 · 5,8982025 · 5,9492024 · 4,7902023 · 4,3562022 · 4,1412021 · 4,4172020 · 4,9962019 · 5,1452018 · 5,2002017 · 4,9442016 · 8512015 · 6292014 · 5622013 · 4,7602012 · 4572011 · 4612010 · 5152009 · 4302008 · 7052007 · 6542006 · 7262005 · 5852004 · 4222003 · 2,9752002 · 4472001 · 4092000 · 4291999 · 3321998 · 2551997 · 4731996 · 7691995 · 6321994 · 6981993 · 4171992 · 4781991 · 3561990 · 3911989 · 3631988 · 5171987 · 592
EUVIMED